0.46

9.79% 0.041

Nextcure Inc (NXTC)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt NXTC? Forum Prognose

Schlusskurs vom Vortag:

$0.419

Offen:

$0.4301

24-Stunden-Volumen:

321.69K

Relative Volume:

2.42

Marktkapitalisierung:

$10.33M

Einnahmen:

Nettoeinkommen (Verlust:

$-58.52M

KGV:

-0.2201

EPS:

-2.09

Netto-Cashflow:

$-45.03M

1W Leistung:

+27.35%

1M Leistung:

-19.16%

6M Leistung:

-66.91%

1J Leistung:

-64.34%

1-Tages-Spanne:

$0.395

$0.499

1-Wochen-Bereich:

$0.3499

$0.499

52-Wochen-Spanne:

$0.224

$1.8199

Nextcure Inc Stock (NXTC) Company Profile

Firmenname

Nextcure Inc

Sektor

Healthcare (1154)

Branche

Biotechnology (677)

Telefon

240-399-4900

Adresse

9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD

Mitarbeiter

Twitter

@nextcureinc

Nächster Verdiensttermin

2025-03-07

Neueste SEC-Einreichungen

NXTC's Discussions on Twitter

Vergleichen Sie NXTC mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NXTC Nextcure Inc	0.46	10.33M	0	-58.52M	-45.03M	-2.09
VRTX Vertex Pharmaceuticals Inc	493.84	122.76B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	602.64	61.38B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	614.76	36.37B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	251.56	30.12B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	244.90	24.70B	3.81B	-644.79M	-669.77M	-6.24

Nextcure Inc Stock (NXTC) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2022-11-04	Herabstufung	Ladenburg Thalmann	Buy → Neutral
2022-03-01	Eingeleitet	Ladenburg Thalmann	Buy
2021-03-05	Hochstufung	Truist	Hold → Buy
2021-01-15	Herabstufung	BofA Securities	Neutral → Underperform
2020-07-16	Hochstufung	The Benchmark Company	Hold → Buy
2020-07-13	Herabstufung	ROTH Capital	Buy → Neutral
2020-07-13	Herabstufung	SunTrust	Buy → Hold
2020-06-01	Herabstufung	BofA/Merrill	Buy → Neutral
2020-06-01	Herabstufung	The Benchmark Company	Buy → Hold
2020-05-26	Eingeleitet	JMP Securities	Mkt Outperform
2020-03-24	Eingeleitet	The Benchmark Company	Buy
2020-03-02	Eingeleitet	ROTH Capital	Buy
2020-01-13	Eingeleitet	SunTrust	Buy
2019-12-05	Eingeleitet	Needham	Buy
2019-11-26	Eingeleitet	BTIG Research	Buy
2019-07-09	Eingeleitet	BofA/Merrill	Buy
2019-06-03	Eingeleitet	Morgan Stanley	Overweight
2019-06-03	Eingeleitet	Piper Jaffray	Overweight

Alle ansehen

Nextcure Inc Aktie (NXTC) Neueste Nachrichten

08:02 AM

Is Nextcure Inc’s -69.93% Fall This Year Is A Better Investing Opportunity? - Marketing Sentinel

08:02 AM

Apr 24, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 24, 2025

Apr 10, 2025

NextCure Updates Presentation on LNCB74 Clinical Trial - TipRanks

Apr 10, 2025

NextCure stock hits 52-week low at $0.3 amid sharp decline - Investing.com Australia

Apr 10, 2025

Apr 09, 2025

NextCure stock hits 52-week low at $0.3 amid sharp decline By Investing.com - Investing.com South Africa

Apr 09, 2025

Apr 04, 2025

NextCure to Present at 24th Annual Needham Virtual Healthcare Conference - The Manila Times

Apr 04, 2025

Cancer Therapy Breakthrough? NextCure's Major Presentation at Needham Healthcare Conference - Stock Titan

Apr 04, 2025

Apr 03, 2025

CLASS ACTION UPDATE for PLAN, NXTC and BTU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders - ACCESS Newswire

Apr 03, 2025

Apr 01, 2025

NextCure stock plunges to 52-week low, hits $0.46 - Investing.com India

Apr 01, 2025

NextCure stock plunges to 52-week low, hits $0.46 By Investing.com - Investing.com Australia

Apr 01, 2025

Mar 25, 2025

NextCure stock hits 52-week low at $0.55 amid market challenges By Investing.com - Investing.com South Africa

Mar 25, 2025

NextCure stock hits 52-week low at $0.55 amid market challenges - Investing.com India

Mar 25, 2025

Mar 20, 2025

ROSEN, A LEADING LAW FIRM, Reminds NextCure, Inc. Investors of Important November 20 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – NXTC - Business Wire

Mar 20, 2025

Mar 19, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Mar 19, 2025

Mar 18, 2025

H.C. Wainwright maintains Buy rating, $3 target on NextCure stock - Investing.com India

Mar 18, 2025

H.C. Wainwright maintains Buy rating, $3 target on NextCure stock By Investing.com - Investing.com South Africa

Mar 18, 2025

NextCure’s (NXTC) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Mar 18, 2025

Mar 17, 2025

NextCure stock plunges to 52-week low at $0.66 amid market challenges - Investing.com Australia

Mar 17, 2025

Mar 13, 2025

NextCure (NXTC) Projected to Post Quarterly Earnings on Thursday - Defense World

Mar 13, 2025

Mar 10, 2025

NextCure Provides Business Update and Reports Full Year 2024 Financial Results - The Manila Times

Mar 07, 2025

Mar 06, 2025

NextCure, Inc. Completes First Cohort of Phase 1 Trial for LNCB74 and Plans for Backfill Cohorts - Nasdaq

Mar 06, 2025

Can NextCure's $68M Cash Support Its Cancer Drug Development Through 2026? - StockTitan

Mar 06, 2025